MISC

査読有り
2019年4月

Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease: The LUBIPRONE, double-blind, randomized, placebo-controlled, phase II study

JOURNAL OF HEPATOLOGY
  • Kessoku Takaomi
  • ,
  • Imajo Kento
  • ,
  • Ogawa Yuji
  • ,
  • Kobayashi Takashi
  • ,
  • Honda Yasushi
  • ,
  • Kato Takayuki
  • ,
  • Tomeno Wataru
  • ,
  • Kato Shingo
  • ,
  • Higurashi Takuma
  • ,
  • Yoneda Masato
  • ,
  • Kirikoshi Hiroyuki
  • ,
  • Kubota Kazumi
  • ,
  • Taguri Masataka
  • ,
  • Yamanaka Takeharu
  • ,
  • Usuda Haruki
  • ,
  • Wada Koichiro
  • ,
  • Saito Satoru
  • ,
  • Nakajima Atsushi

70
開始ページ
E1
終了ページ
DOI
10.1016/S0618-8278(19)30001-5


リンク情報
DOI
https://doi.org/10.1016/S0618-8278(19)30001-5
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000463481700002&DestApp=WOS_CPL